Use of antidepressants in patients with moderate-to-severe Crohn's disease

被引：0
|
作者：
Lichtenstein, GR
Colombel, JF
Yan, S
Bala, M
Olson, A
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Hop Calmette, Lille, France
[3] Centocor Inc, Malvern, PA 19355 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2004年 / 99卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
773
引用
收藏
页码：S250 / S251
页数：2
相关论文
共 50 条
  • [1] Upadacitinib for the treatment of moderate-to-severe Crohn's disease
    Hanzel, Jurij
    Ma, Christopher
    Jairath, Vipul
    IMMUNOTHERAPY, 2024, 16 (06) : 345 - 357
  • [2] A new treatment for moderate-to-severe Crohn's disease
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2008, 108 (05) : 65 - 65
  • [3] Profile of ustekinumab and its potential in patients with moderate-to-severe Crohn's disease
    Tuskey, Anne
    Behm, Brian W.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2014, 7 : 173 - 179
  • [4] The role of vedolizumab in patients with moderate-to-severe Crohn's disease and ulcerative colitis
    Shahidi, Neal
    Bressler, Brian
    Panaccione, Remo
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (03) : 330 - 338
  • [5] Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease
    Peyrin-Biroulet, Laurent
    Chapman, J. Casey
    Colombel, Jean-Frederic
    Caprioli, Flavio
    D'Haens, Geert
    Ferrante, Marc
    Schreiber, Stefan
    Atreya, Raja
    Danese, Silvio
    Lindsay, James O.
    Bossuyt, Peter
    Siegmund, Britta
    Irving, Peter M.
    Panaccione, Remo
    Cao, Qian
    Neimark, Ezequiel
    Wallace, Kori
    Anschutz, Toni
    Kligys, Kristina
    Duan, W. Rachel
    Pivorunas, Valerie
    Huang, Xiu
    Berg, Sofie
    Shu, Lei
    Dubinsky, Marla
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (03): : 213 - 223
  • [6] Efficacy of Adalimumab in Moderate-to-Severe Pediatric Crohn's Disease
    Viola, Franca
    Civitelli, Fortunata
    Di Nardo, Giovanni
    Barbato, Maria Beatrice
    Borrelli, Osvaldo
    Oliva, Salvatore
    Conte, Francesca
    Cucchiara, Salvatore
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (10): : 2566 - 2571
  • [7] Variables associated with progression of moderate-to-severe Crohn's disease
    Beda Sacramento, Carolina da Silva
    Motta, Marina Pamponet
    Alves, Candida de Oliveira
    Mota, Jaciane Araujo
    Codes, Lina Maria Goes de
    Ferreira, Reginaldo Freitas
    Silva, Pedro de Almeida
    Palmiro, Larissa do Prado
    Barbosa, Rafael Miranda
    Andrade, Mariana Nery
    Andrade, Vitor Damasceno
    Vasconcelos, Vitor Brandao
    Thiara, Bernardo Wasconcellos
    Netto, Eduardo Martins
    Santana, Genoile Oliveira
    BMJ OPEN GASTROENTEROLOGY, 2022, 9 (01):
  • [8] How effective is adalimumab for inducing remission in patients with moderate-to-severe Crohn's disease?
    Ghosh, Subrata
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (10): : 540 - 541
  • [9] How effective is adalimumab for inducing remission in patients with moderate-to-severe Crohn's disease?
    Subrata Ghosh
    Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 540 - 541
  • [10] Consistency of treatment benefit with infliximab in patients with moderate-to-severe active Crohn's disease
    Vasiliauskas, E
    Targan, S
    Sands, B
    Hanauer, S
    Mayer, L
    Present, D
    Braakman, T
    DeWoody, K
    Schaible, T
    Rutgeerts, P
    GASTROENTEROLOGY, 1999, 116 (04) : A837 - A837
12345